The AI Innerve Algorithm: Automatic Reproducible Reading for Intraepidermal Nerve Fiber Density Analysis, a New Tool for Small-Fiber Neuropathy Diagnosis [0.03%]
一种自动可重复的皮肤活体感觉神经纤维密度分析新方法——用于小纤维病变诊断的新工具
C Labeyrie,A Lorenzo de Brionne,O Trassard et al.
C Labeyrie et al.
Objectives: To measure intra-observer and interobserver correlations and reading times for visual and artificial intelligence algorithm-assisted reading (innerve) of intraepidermal small nerve fiber density (IENFD) in ski...
Gene-Environment Interactions for Alzheimer's Disease Pathology in Cognitively Normal Adults: The CABLE Study [0.03%]
cognitively normal老年人中阿尔茨海默病病理与基因-环境互作：CABLE研究
Ze-Xin Guo,Xiao-Yu He,Yi-Jun Ge et al.
Ze-Xin Guo et al.
Background: Characterizing the gene-environment interactions with early pathological changes in Alzheimer's disease (AD) is critical to precision medicine. ...
Older Adults, Anti-Amyloid Therapy, and Frailty: What Oncology Can Teach Us [0.03%]
老年患者、抗淀粉样蛋白疗法和衰弱：肿瘤学能告诉我们什么？
Miguel Germán Borda,Kevin O&#x;Hara-Veintimilla,Dag Aarsland
Miguel Germán Borda
Background: Anti-amyloid therapies, such as lecanemab or donanemab, represent the first disease-modifying treatments approved for early Alzheimer's disease (AD) in individuals with confirmed amyloid pathology. Their imple...
Mortality From Amyotrophic Lateral Sclerosis in Finland 1987-2022 [0.03%]
1987-2022年芬兰肌萎缩侧索硬化症死亡率变化趋势及其与环境因素的关系
Milla Laine,Jani Raitanen,Anssi Auvinen
Milla Laine
Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. We assessed changes in the mortality from ALS in Finland from 1987 to 2022. ...
Palliative Care in Europe: Safeguarding Compassion Amidst Changing End-of-Life Policies and Expanding Access to Medically Assisted Dying Position Statement on behalf of the European Academy of Neurology, the European Federation of Neurological Associations and OneNeurology [0.03%]
欧洲的姑息治疗：在不断变化的末期生命政策和日益扩大的医疗辅助死亡获取途径中守护同情心——欧洲神经学学院、欧洲神经科学会联合会和OneNeurology的立场文件
Katarina Rukavina,Marianne de Visser,Elena Moro et al.
Katarina Rukavina et al.
Reappraisal of the Diagnostic Significance of Transcranial Magnetic Stimulation and Triple Stimulation in Amyotrophic Lateral Sclerosis [0.03%]
肌萎缩侧索硬化诊断中经颅磁刺激及三重刺激检查意义的再评价
Birgit Andersen,Christian Krarup
Birgit Andersen
Objective: To reassess the importance of transcranial magnetic stimulation (TMS), including the triple stimulation technique (TST), to detect upper motor neuron (UMN) involvement in amyotrophic lateral sclerosis (ALS). ...
Epidemiology of Progressive Supranuclear Palsy in Navarre, Spain: A Population-Based Study [0.03%]
西班牙纳瓦拉进行的进行性核上性麻痹的流行病学研究
P Arrondo Gómez,E Vicente,G Martí-Andrés et al.
P Arrondo Gómez et al.
Background: Epidemiological studies carried out on progressive supranuclear palsy (PSP) provide heterogeneous data. Our aim has been to analyze incidence, point prevalence, survival, and time to diagnosis of PSP in Navarr...
Observational Study
European journal of neurology. 2026 Apr;33(4):e70592. DOI:10.1111/ene.70592 2026
Trans-Synaptic Retrograde Retinal Degeneration After Post-Chiasmatic Stroke: A Systematic Review of Empirical Evidence [0.03%]
视交叉后脑卒后再发性视网膜退行性变的系统评价研究证据体系
Francesca Crespi,Giacomo Guidali,Lisa Melzi et al.
Francesca Crespi et al.
Background: Retrograde trans-synaptic degeneration (RTSD) refers to the progressive loss of retinal cells following damage to the post-geniculate visual pathway. The advent of optical coherence tomography (OCT) has allowe...
Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper [0.03%]
痴呆症神经心理学量表的低敏感性阻碍了治疗潜在获益的检测：立场文件
Simona Luzzi,Julie S Snowden
Simona Luzzi
Background: Despite the advent of Disease Modifying Therapies (DMTs) for Alzheimer's Disease (AD), the approval and commercialization of anti-amyloid monoclonal antibodies has been slow and contentious, particularly in Eu...
Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity with Botulinum Neurotoxin A in Multiple Indications-Comment on Recommending IncobotulinumtoxinA as First-Line to Prevent Secondary Treatment Failure [Letter] [0.03%]
肉毒杆菌毒素A治疗失败和免疫原性的系统评价与meta分析及相关评论-推荐incyobotulinumtoxa作为一线药物预防继发性治疗失败[信]
Fabiano Nadson Magacho-Vieira
Fabiano Nadson Magacho-Vieira